Susanna High

Susanna High

Chief Executive Officer at
Paragon Therapeutics, Inc.
58 year
Health Technology
Consumer Services
Commercial Services

Profile

Susanna G.
High
is currently the Chief Executive Officer at Paragon Therapeutics, Inc. She previously held positions as the Director-Corporate Strategy at Millennium Pharmaceuticals, Inc. from 2001 to 2007, the Chief Operating Officer at bluebird bio, Inc. from 2016 to 2019, and the SVP-Strategy & Business Integration at Alnylam Pharmaceuticals, Inc. from 2007 to 2016.
Prior to that, she worked as a Management Consultant at Accenture LLC from 1996 to 2001.
Ms. High also served as the Chief Operating Officer at Dyne Therapeutics, Inc. from 2020 to 2024.
She graduated from the University of Bocconi and holds an MBA from MIT Sloan School of Management, which she received in 1996.

Susanna High active positions

CompaniesPositionStart
Chief Executive Officer 2024-11-20

Former positions of Susanna High

CompaniesPositionEnd
DYNE THERAPEUTICS, INC. Chief Operating Officer 2024-09-30
GENETIX BIOTHERAPEUTICS, INC. Chief Operating Officer 2019-01-03
ALNYLAM PHARMACEUTICALS, INC. Director/Board Member 2008-05-31
Corporate Officer/Principal 2006-12-31
Corporate Officer/Principal 2000-12-31
See the detail of Susanna High's experience

Training of Susanna High

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

82

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Health Technology

Commercial Services